Clustering trends of melanoma incidence and mortality: A worldwide assessment from 1995 to 2019

Abstract

Background: Melanoma is a skin cancer that has higher mortality among cutaneous malignant tumours. Tumour incidence in most world regions is rising.Here, we intend to highlight these trends in the world. Methods:We used the global burden of disease dataset to assess the incidence and mortality of melanoma from 1995 to 2019 in 204 countries/territories. To identify country/territory groups with similar trends of melanoma incidence and mortality, a model-based clustering with a mixture of multivariate t-distributions was used.Results: Australia and New Zealand had the largest incidence and mortality rates. Men in Egypt and women in Sri Lanka and Guam had the lowest incidence and mortality rates. The clustering analysis revealed 4 classes of incidence in both gender and 3 and 2 classes of mortality in male and female, respectively. All groups had a growing incidence rate in both gender, similar to the worldwide trend. In 10% of the countries/territories, central and Western Europe, the incidence increase rate was greater than in the countries/territories with the greatest incidence. The total mortality rate for men was steadily growing, although it was decreasing in Asian and African countries/territories. Overall, the mortality rate for women remained relatively steady over time. Conclusion:Due to the increasing trend of melanoma in the world, primary and secondary prevention of this disease, especially in areas with higher incidence and mortality, is essential. Raising awareness about the disease is helpful in prevention and early detection of melanoma.

Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin

“…Melanoma is a skin cancer formed by malignant melanocytes, the incidence of which is increasing rapidly worldwide. 1 Although chemotherapy is widely used for treating melanoma, its effectiveness is limited due to severe side effects. As a result, there is an urgent need for a new treatment approach.…”

“…Melanoma is a prevalent type of tumor that has been on the rise in recent years, 1 posing a significant threat to human life. Currently, treatment options for melanoma consist of targeted therapy, immunotherapy, and surgical resection.…”

Identification of novel disulfidptosis‐related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients

“…Skin cutaneous melanoma, a malignant tumor that arises from melanocytes, is implicated in 90% of skin cancer‐associated mortalities and is recognized as one of the most aggressive skin malignancies. 26 Based on the high SKCM mortality rates, it is crucial to assign classifier models to predict prognosis as early as possible. Even though screening, diagnosis and treatment of SKCM have made great progress, patients with advanced stage melanoma still have a poor prognosis.…”

Spain’s Rising Melanoma Threat: A Comprehensive 30-Year Analysis (1990–2019)

“…The Global Burden of Disease (GBD) study provides a valuable resource, meticulously tracking various diseases and injuries worldwide, including melanoma [ 13 ]. Thanks to the GBD study, detailed melanoma incidence data exist for numerous regions and countries [ 14 , 15 , 16 , 17 , 18 ]. However, Spain lacks comparable analyses, creating a significant gap in understanding the nationwide burden of this disease.…”